EpiPen EpiPen
Stories About

EpiPen

An EpiPen Jr. epinephrine auto-injector. Some EpiPens have been recalled from the U.S. market over concerns that they could fail to activate when people try to use them. Chris Ratcliffe/Bloomberg via Getty Images hide caption

toggle caption
Chris Ratcliffe/Bloomberg via Getty Images

Auvi-Q was pulled from the market in 2015 because of quality concerns. The drug's maker says the problems have been solved and that the product will be available in 2017. AP hide caption

toggle caption
AP

Mylan CEO Heather Bresch holds up an EpiPen two-pack while testifying about price increases to the House Oversight and Government Reform Committee on Sept. 21. Pablo Martinez Monsivais/AP hide caption

toggle caption
Pablo Martinez Monsivais/AP

Rethinking Automatic Insurance Coverage For Preventive Health Care

  • Download
  • <iframe src="https://www.npr.org/player/embed/497040284/497423632" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Heather Bresch, CEO of Mylan Pharmacueticals, will face lawmakers' questions Wednesday about the company's steep price hikes for the company's life-saving EpiPen auto-injector. Dale Sparks/AP hide caption

toggle caption
Dale Sparks/AP

Mylan CEO Claims EpiPens Aren't As Profitable As Everyone Thinks

  • Download
  • <iframe src="https://www.npr.org/player/embed/494879607/494914776" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Where are the generic alternatives to EpiPen and other expensive drugs that have lost patent protection? Victor J. Blue/Bloomberg via Getty Images hide caption

toggle caption
Victor J. Blue/Bloomberg via Getty Images

Mylan, the maker of EpiPen, says it will sell a generic version for $300 for a two-pack, a price that consumer advocates say is still too high. The device is used to treat severe allergic reactions. Daniel Acker/Bloomberg via Getty Images hide caption

toggle caption
Daniel Acker/Bloomberg via Getty Images

Maker Of EpiPen To Sell Generic Version For Half The Price

  • Download
  • <iframe src="https://www.npr.org/player/embed/491797051/491848114" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The cost of an EpiPen two-pack has risen more than 400 percent in recent years. The drug is used to halt severe allergic reactions. Joe Raedle/Getty Images hide caption

toggle caption
Joe Raedle/Getty Images

Discounts Aren't Enough to Halt Outrage At High EpiPen Prices

  • Download
  • <iframe src="https://www.npr.org/player/embed/491372193/491390054" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript